Clinical and Translational Research
Copyright ©The Author(s) 2022.
World J Clin Cases. Feb 16, 2022; 10(5): 1485-1497
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1485
Table 2 Overall 3-year survival rate of gastric patients stratified by age
Prior initial cancer siteAll-cause survival (95%CI)
Overall
Age < 65 yr (%)
Age ≥ 65 yr (%)
No prior cancer26.42 (25.90, 26.94)28.95 (28.14, 29.77)24.49 (23.82, 25.16)
With prior cancer25.20 (23.80, 26.63)30.12 (26.68, 33.62)24.08 (22.55, 25.65)
Prostate 24.79 (21.39, 28.32)23.33 (16.23, 31.21)25.16 (21.35, 29.14)
Gastrointestinal 26.47 (23.96, 29.04)31.13 (22.60, 40.03)26.00 (23.38, 28.68)
Hematologic 28.06 (22.75, 33.58) 42.17 (31.11, 52.80)22.16 (16.49, 28.38)
Breast 26.80 (22.96, 30.78)33.27 (25.47, 41.25)24.36 (20.04, 28.92)
Genitourinary 23.64 (20.14, 27.30)34.29 (25.39, 43.35)21.06 (17.36, 25.02)
Lung 19.32 (13.87, 25.45)12.50 (3.95, 26.23)20.83 (14.64, 27.79)
Other 22.90 (18.79, 27.26)24.61 (16.44, 33.66)22.33 (17.66, 27.35)